STOCK TITAN

Vistra CEO reports 10b5-1 trades: option exercises and sales

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Vistra Corp. (VST) President & CEO (also a Director) reported Form 4 transactions under a Rule 10b5-1 trading plan adopted on June 12, 2025. On 10/17/2025 and 10/20/2025, he exercised 24,000 stock options each day at an exercise price of $19.68 and sold 21,367 shares at a weighted-average price of $207.66 and 21,371 shares at $204.57, respectively. The sales include shares for cashless exercise and to cover taxes.

Following the reported transactions, the executive directly held 287,859 shares. Indirect holdings include 701,514 shares by JAMEB, LP (jointly owned with spouse), 34,000 shares by the James A. Burke 2012 Irrevocable Trust, and 259 shares by the Marti E. Burke 2012 Irrevocable Trust.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 4: option exercises and planned sales under 10b5-1.

The CEO exercised options at an exercise price of $19.68 on 10/17/2025 and 10/20/2025, then sold shares at weighted-average prices of $207.66 and $204.57. The filing states these were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025.

Part of the sold shares covered cashless exercise and taxes, per the notes. After the transactions, direct holdings were 287,859 shares, with additional indirect holdings via JAMEB, LP and two irrevocable trusts. This is administrative and does not, by itself, signal operational changes.

Insider BURKE JAMES A
Role President and CEO
Sold 42,738 shs ($8.81M)
Type Security Shares Price Value
Exercise 2018 Employee Stock Option (right to buy) 24,000 $0.00 --
Exercise Common Stock 24,000 $19.68 $472K
Sale Common Stock 21,371 $204.57 $4.37M
Exercise 2018 Employee Stock Option (right to buy) 24,000 $0.00 --
Exercise Common Stock 24,000 $19.68 $472K
Sale Common Stock 21,367 $207.66 $4.44M
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: 2018 Employee Stock Option (right to buy) — 102,052 shares (Direct); Common Stock — 309,230 shares (Direct); Common Stock — 701,514 shares (Indirect, By JAMEB, LP, a limited partnership jointly owned by Reporting Person and his spouse)
Footnotes (1)
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025. Includes an aggregate of approximately (i) 2,283 shares sold for the cashless exercise of the stock options; and (ii) 8,550 shares sold to pay taxes in connection with the exercise of the stock options. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.57 to $207.67, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Includes an aggregate of approximately (i) 2,316 shares sold for the cashless exercise of the stock options; and (ii) 8,537 shares sold to pay taxes in connection with the exercise of the stock options. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.53 to $204.57, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Options vested 50% 4 years from the grant date with the remaining 50% vesting 5 years from the grant date.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BURKE JAMES A

(Last) (First) (Middle)
6555 SIERRA DRIVE

(Street)
IRVING TX 75039

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vistra Corp. [ VST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/17/2025 M(1) 24,000 A $19.68 306,597 D
Common Stock 10/17/2025 S(1) 21,367(2) D $207.66(3) 285,230 D
Common Stock 10/20/2025 M(1) 24,000 A $19.68 309,230 D
Common Stock 10/20/2025 S(1) 21,371(4) D $204.57(5) 287,859 D
Common Stock 701,514 I By JAMEB, LP, a limited partnership jointly owned by Reporting Person and his spouse
Common Stock 34,000 I By the James A. Burke 2012 Irrevocable Trust, dated 12/03/2012
Common Stock 259 I By the Marti E. Burke 2012 Irrevocable Trust, dated 10/16/2012
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2018 Employee Stock Option (right to buy) $19.68 10/17/2025 M(1) 24,000 (6) 04/09/2027 Common Stock 24,000 $0 126,052 D
2018 Employee Stock Option (right to buy) $19.68 10/20/2025 M(1) 24,000 (6) 04/09/2027 Common Stock 24,000 $0 102,052 D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.
2. Includes an aggregate of approximately (i) 2,283 shares sold for the cashless exercise of the stock options; and (ii) 8,550 shares sold to pay taxes in connection with the exercise of the stock options.
3. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $207.57 to $207.67, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
4. Includes an aggregate of approximately (i) 2,316 shares sold for the cashless exercise of the stock options; and (ii) 8,537 shares sold to pay taxes in connection with the exercise of the stock options.
5. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.53 to $204.57, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
6. Options vested 50% 4 years from the grant date with the remaining 50% vesting 5 years from the grant date.
Remarks:
/s/ Daniela Gutierrez, as Attorney-in-Fact 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Vistra (VST) report?

The CEO exercised 24,000 options on 10/17/2025 and 24,000 on 10/20/2025 at $19.68, then sold 21,367 shares at $207.66 and 21,371 shares at $204.57.

Were the Vistra (VST) insider sales under a trading plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on June 12, 2025.

How many Vistra (VST) shares does the CEO own after these transactions?

Direct holdings were 287,859 shares. Indirect holdings include 701,514 shares by JAMEB, LP, 34,000 shares by the James A. Burke 2012 Irrevocable Trust, and 259 shares by the Marti E. Burke 2012 Irrevocable Trust.

What were the sale price ranges disclosed in the Form 4?

Weighted-average prices were $207.66 (range $207.57–$207.67) and $204.57 (range $204.53–$204.57).

Did the Form 4 note reasons for some shares being sold?

Yes. The notes state shares were sold for cashless exercise of options and to pay taxes related to the option exercises.

What options were exercised by the Vistra (VST) CEO?

2018 employee stock options with a $19.68 exercise price and an expiration date of April 9, 2027.